Qiagen (NYSE:QGEN) announces plans to launch the Access Anti-SARS-CoV-2 Antigen Test designed to generate ~30 tests per hour from swab specimens using a small digital detection system.
The test, developed in collaboration with Australian digital diagnostics company Ellume, can generate a result in less than 15 minutes and is suited for high volume environments requiring fast accurate results.
Two versions of the Antigen Test, one for labs and one for point-of-care use, will be commercially available next quarter.
Feasibility tests showed sensitivity of at least 90% and specificity of 100%.
https://seekingalpha.com/news/3612278-qiagen-readies-launch-of-rapid-portable-coronavirus-test
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.